Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate


Gode F., Karagoz C., POSACI C., Saatli B., Uysal D., SEÇİL M., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.284, no.4, pp.923-929, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 284 Issue: 4
  • Publication Date: 2011
  • Doi Number: 10.1007/s00404-010-1790-9
  • Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.923-929
  • Keywords: Polycystic ovary syndrome, Cardiovascular risk, Oral contraceptives, Metabolic risk, INTIMA-MEDIA THICKNESS, BRACHIAL ENDOTHELIAL FUNCTION, COMBINED ORAL-CONTRACEPTIVES, C-REACTIVE PROTEIN, INSULIN-RESISTANCE, YOUNG-WOMEN, NONOBESE WOMEN, METFORMIN, PREVALENCE, DISEASE
  • Dokuz Eylül University Affiliated: Yes

Abstract

We aimed to evaluate the alteration of cardiovascular and metabolic risk parameters of polycystic ovary syndrome (PCOS) patients after a 6-month treatment with an oral contraceptive (OC) containing cyproterone acetate (CPA).